Anúncio
Anúncio
INBX
Inhibrx Biosciences, Inc. Common Stock
72.89
USDPatrocinado
-2.31
-3.08%
09 de jan., 15:59 UTC -5
Encerrado
Pós-Mercado
72.86
-0.03
-0.03%
Relatórios de Lucros INBX
Rácio de surpresa positiva
INBX separação 10 de 21 últimas estimativas.
48%
Próximo Relatório
Data do Próximo Relatório
16 de mar. de 2026
Estimate for Q4 25 (Revenue/ EPS)
--
/-$2.11
Mudanças implicadas de Q3 25 (Revenue/ EPS)
--
/-7.05%
Mudanças implicadas de Q4 24 (Revenue/ EPS)
-100.00%
/-31.72%
Inhibrx Biosciences, Inc. Common Stock earnings per share and revenue
On 14 de nov. de 2025, INBX reported earnings of -2.27 USD per share (EPS) for Q3 25, missing the estimate of -1.75 USD, resulting in a -30.11% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a +6.04% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 3 analistas forecast an EPS of -2.11 USD, with revenue projected to reach -- USD, implying an diminuir of -7.05% EPS, and aumentar of 0.00% in Revenue from the last quarter.
FAQ
What were Inhibrx Biosciences, Inc. Common Stock's earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Inhibrx Biosciences, Inc. Common Stock reported EPS of -$2.27, missing estimates by -30.11%, and revenue of $0.00, 0% as expectations.
How did the market react to Inhibrx Biosciences, Inc. Common Stock's Q3 2025 earnings?
The stock price moved up 6.04%, changed from $74.62 before the earnings release to $79.13 the day after.
When is Inhibrx Biosciences, Inc. Common Stock expected to report next?
The next earning report is scheduled for 16 de mar. de 2026.
What are the forecasts for Inhibrx Biosciences, Inc. Common Stock's next earnings report?
Based on 3
analistas, Inhibrx Biosciences, Inc. Common Stock is expected to report EPS of -$2.11 and revenue of -- for Q4 2025.
Which companies are reporting earnings today?
Verificar FXEmpire's Earnings Calendar for today's list of reporting companies.
Anúncio